USADA announced today that U.S. track & field athlete, Andrew Carnes, of Northfield, Ohio, has accepted a two-year period of ineligibility for a non-analytical anti-doping rule violation based on his purchase, possession and use of synthetic erythropoietin (EPO).
EPO, a synthetic hormone used to stimulate the body’s production of red blood cells, thereby increasing oxygen transport and aerobic power, is a prohibited substance in the class of Peptide Hormones, Growth Factors and Related Substances under the USADA Protocol for Olympic and Paralympic Movement Testing and the International Association of Athletic Federations (IAAF) anti-doping rules, both of which have adopted the World Anti-Doping Code (“Code”) and the World Anti-Doping Agency Prohibited List.
Carnes promptly admitted his violation to USADA, after being confronted with the evidence already in USADA’s possession. Carnes’ two-year period of ineligibility began on October 25, 2013, the day he accepted responsibility for his anti-doping rule violation. Additionally, Carnes is disqualified from all competitive results achieved on and subsequent to June 1, 2011, the date he first committed the anti-doping rule violation, including forfeiture of any medals, points and prizes.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, the agency manages a drug reference hotline, Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.